Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CBER Director Midthun Retiring; Legacy Includes Biosimilar Principles, Avastin Withdrawal

Oct 02 2015

• By Derrick Gingery

Related Content

FDA Grants Hearing To Appeal Avastin Breast Cancer Withdrawal

Feb 24 2011

FDA’s Acting Chief Scientist Offers Vaccine Continuity As Goodman Departs

Jan 10 2014

Follow-On Biologics' Bumpy Pathway: Was The CBO Savings Score Too High?

May 17 2010

FDA’s Goodman Moving Up: Named Acting Chief Medical Officer, Appointed To CER Panel

Mar 19 2009

CDER Pharmaceutical Quality Office Gains Permanent Director

Sep 25 2015

CDER’s Woodcock Retiring? Rumors Never Go On Furlough

Oct 14 2013

Related Companies

Genentech, Inc.

Novartis AG

Additional Topics

United States Regulation BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window